Craig Hilts is a partner in the Corporate Practice Group. His practice focuses on advising domestic and foreign issuers and investment banks in capital markets transactions, corporate governance and public company reporting matters, with a particular emphasis on the life sciences and technology industries.

Mr. Hilts has successfully represented clients in a wide range of complex capital markets transactions, including numerous initial public offerings, follow-on equity offerings, PIPEs, at-the-market offerings senior debt offerings, convertible debt offerings and liability management transaction.

Mr. Hilts regularly advises life companies on financing transactions, SEC reporting requirements, complex disclosure issues, stock exchange requirements and corporate governance issues. He also frequently represents investment banks in initial public offerings and follow-on equity offerings in the life sciences industry. 

Community Activities

Mr. Hilts served on the Business Transactions section of the Boston Bar Association from 2018–2020. 

For several years, Mr. Hilts was a member of the Young Executive Board of a nonprofit organization dedicated to motivating young students in disadvantaged neighborhoods to become readers by bringing authors to participate in in-class discussions. 

Mr. Hilts completed the 2013 New York Marathon.

Experience

    • Advised numerous issuers, including Verve Therapeutics, Cue Health,  Pandion Therapeutics, Fulcrum Therapeutics, Constellation Pharmaceuticals, Translate Bio, Apellis Pharmaceuticals and Aileron Therapeutics on their initial public offerings.
    • Advised investment banks on the initial public offerings of Ikena Oncology, Dynatrace, Graybug Vision and Rhythm Pharmaceuticals.
    • Advised on the public follow-on offerings of Verve Therapeutics, Fulcrum Therapeutics, Apellis Pharmaceutics, Solid Biosciences, Aileron Therapeutics, and PAR Technology Corporation, among others.
    • Advised TechTarget in its $360 million private placement of convertible notes.

Recognition

  • Named a 2021 Top Rising Star by The Deal

Insights & News

Credentials

  • Education

    • JD, Catholic University of America, Columbus School of Law, 2008

    • BA, Economics and Political Science, Wake Forest University, 2003

  • Admissions

    • Massachusetts

    • New York

Credentials